Evidence map›Paper›PMID 25045456›Full record

ReviewMediterranean journal of hematology and infectious diseases2014

Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin.

Massimiliano Salati, Marina Cesaretti, Matteo Macchia, Mufid El Mistiri, Massimo Federico

Abstract readReview
In one paragraph

Review in Mediterranean journal of hematology and infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. NFATc1 is Suppressed in Tumor Microenvironment of Hodgkin Lymphoma.Asian Pacific journal of cancer prevention : APJCP · 2021
    Article
  5. Hodgkin Reed-Sternberg-Like Cells in Non-Hodgkin Lymphoma.Diagnostics (Basel, Switzerland) · 2020
    Review
  6. Article
  7. Radiogenomics and Its Role in Lymphoma.Current hematologic malignancy reports · 2020
    Review
  8. Resources-Stratified Guidelines for Classical Hodgkin Lymphoma.International journal of environmental research and public health · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Massimiliano SalatiDepartment of Diagnostic, Clinical and Public Health Medicine, Modena Cancer Center, Italy.
Marina CesarettiDepartment of Diagnostic, Clinical and Public Health Medicine, Modena Cancer Center, Italy.
Matteo MacchiaDepartment of Diagnostic, Clinical and Public Health Medicine, Modena Cancer Center, Italy.
Mufid El MistiriHamad Medical Corporation, National Center for Cancer Care and Research (NCCCR), Qatar.
Massimo FedericoDepartment of Diagnostic, Clinical and Public Health Medicine, Modena Cancer Center, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidemiology of Hodgkin lymphoma (HL) has always been a source of fascination to researchers due to its heterogeneous characteristics of presentation. HL is an uncommon neoplasm of B-cell origin with an incidence that varies significantly by age, sex, ethnicity, geographic location and socioeconomic status. This complex pattern was also found to be replicated among Mediterranean basin populations. HL incidence rates progressively decreased from industrialized European countries such as France (ASR=2.61) and Italy (ASR=2.39) to less developed nations such as Albania (ASR=1.34) and Bosnia Herzegovina (ASR=1.1). Regarding HL mortality we have found that countries with the lowest incidence rates show the highest number of deaths from this cancer and viceversa. Finally, a wide gap in terms of survival was showed across the Mediterranean basin with survival rates ranged from 82.3% and 85.1% among Italian men and women, to 53.3 % and 59.3% among Libyan men and women, respectively. Factors such as the degree of socio-economic development, the exposure to risk factors westernization-related, the availability of diagnostic practices along with different genetic susceptibilities to HL may explain its variation across Mediterranean countries. Furthermore, the lack of health resources decisively contribute to the poor prognosis recorded in less developed region. In the future, the introduction of appropriate and accessible treatment facilities along with an adequate number of clinical specialists in the treatment of HL and other cancers are warranted in order to improve the outcomes of affected patients and treat a largely curable type of cancer in disadvantaged regions.

Identifiers

PMID25045456
PMCPMC4103499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.